Table 1.
Overall Survival | ||||
---|---|---|---|---|
| ||||
Variables | Hazard ratio | 95% CI | p-value | |
Age | 0.303 | 0.057 | 0.86 | 0.007* |
CET Volume | 0.703 | 0.415 | 1.059 | 0.1 |
MGMT status | 0.02 | 0 | 1.658 | 0.093 |
| ||||
ADC slope (μm2/s) |
1.177 | 1.016 | 1.482 | 0.002* |
| ||||
Age | 0.922 | 0.766 | 1.111 | 0.354 |
CET Volume | 0.963 | 0.752 | 1.287 | 0.751 |
MGMT status | 0.814 | 0.427 | 1.123 | 0.813 |
| ||||
Dapp slope (μm2/s) |
0.991 | 0.925 | 1.033 | 0.706 |
Kapp slope (a.u) |
0.952 | 0.744 | 1.109 | 0.563 |
| ||||
Age | 0.924 | 0.729 | 1.102 | 0.371 |
CET Volume | 0.923 | 0.735 | 1.151 | 0.449 |
MGMT status | 0.573 | 0.03 | 6.082 | 0.646 |
| ||||
DDC slope (μm2/s) |
1.006 | 0.986 | 1.029 | 0.519 |
α slope (a.u) | 1.079 | 0.81 | 1.46 | 0.582 |
Mean, standard deviation (Std-Dev) and coefficient of variation (CV) were reported for each fit and ROI. The results of normality test (Shapiro-Wilk test) as well as corresponding Student’s or Wilcoxon-Mann-Whitney tests were reported for each fit and ROI